Sign up to read this article for FREE!
After signing up, you'll start to receive regular news updates from us.
Agilent Technologies Announces New Leadership in Biological Systems Division
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: Less than a minute
Agilent Technologies Inc. has announced the appointments of Robert Schueren as vice president and general manager, Genomics; and John Fjeldsted, Ph.D., as general manager, Liquid Chromatography/Mass Spectrometry.
“The life sciences and biological systems business continues to be a key growth driver for Agilent, and the addition of Robert and John strengthens our current leadership team and positions us well for future success,” said Gustavo Salem, vice president and general manager of Agilent’s Biological Systems Division.
Schueren will be responsible for all genomics operations, including microarrays, QPCR and life science reagents. Most recently, he was global head of companion diagnostics, clinical biomarker, and sample operations at Genentech/Roche.
Fjeldsted will be responsible for managing the LC/MS business and driving market share in high-end LC/MS. He has been with Agilent for more than 25 years and played a key role in the tremendous growth of Agilent’s LC/MS unit.
Additionally, George Stafford has joined Agilent as LC/MS hardware R&D manager. Most recently, Stafford held the position of R&D program manager, responsible for Thermo Fisher Scientific’s LC/MS research programs and university collaborations.
“The life sciences and biological systems business continues to be a key growth driver for Agilent, and the addition of Robert and John strengthens our current leadership team and positions us well for future success,” said Gustavo Salem, vice president and general manager of Agilent’s Biological Systems Division.
Schueren will be responsible for all genomics operations, including microarrays, QPCR and life science reagents. Most recently, he was global head of companion diagnostics, clinical biomarker, and sample operations at Genentech/Roche.
Fjeldsted will be responsible for managing the LC/MS business and driving market share in high-end LC/MS. He has been with Agilent for more than 25 years and played a key role in the tremendous growth of Agilent’s LC/MS unit.
Additionally, George Stafford has joined Agilent as LC/MS hardware R&D manager. Most recently, Stafford held the position of R&D program manager, responsible for Thermo Fisher Scientific’s LC/MS research programs and university collaborations.
